Radioidine Treatment After Thyroid Hormone Withdrawal Or rhTSH Stimulation - A Single Centre Retrospective Study In Disseminated Thyroid Cancer In Pediatric Patients

被引:0
|
作者
Handkiewicz-Junak, D. [1 ]
Kropinska, A. [1 ]
Ledwon, A. [1 ]
Paliczka-Cieslik, E. [1 ]
Roskosz, J. [1 ]
Blewaska, A. [1 ]
Kuta, D. [1 ]
Puch, Z. [1 ]
Jarzab, B. [1 ]
机构
[1] MSC Natl Res Inst Oncol, Gliwice, Poland
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-703
引用
收藏
页码:S235 / S235
页数:1
相关论文
共 50 条
  • [31] Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
    Pitoia, Fabian
    Marlowe, Robert J.
    Abelleira, Erika
    Faure, Eduardo N.
    Bueno, Fernanda
    Schwarzstein, Diego
    Julio Lutfi, Ruben
    Niepomniszcze, Hugo
    [J]. JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [32] The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer; a retrospective analysis in a single centre
    Nawarathna, N. J.
    Ratnayake, P.
    Balasooriya, R. S.
    Seneviratne, R. J. K.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 41 - 41
  • [33] Serum thyroglobulin concentration after rhTSH stimulation as a prognostic factor during adjuvant radioiodine treatment of differentiated thyroid cancer
    Handkiewicz-Junak, D.
    Ledwon, A.
    Kropinska, A.
    Roskosz, J.
    Paliczka-Cieslik, E.
    Puch, Z.
    Gawlik, T.
    Olczyk, T.
    Jarzab, B.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S364 - S364
  • [34] Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH
    Lassmann, M
    Hänscheid, H
    Reiners, C
    Thomas, SR
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 900 - 901
  • [35] Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: A retrospective study
    Grenfell, Solveig
    Roos, Daniel
    Rijken, James
    Higgs, Braden
    Kirkwood, Ian
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (02) : 248 - 254
  • [36] The importance of recombinant human. thyroid stimulating hormone in the follow-up and treatment of disseminated thyroid cancer after thyroidectomy
    Skoura, Evangelia
    Rontogianni, Phivi
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2007, 10 (01): : 40 - 47
  • [37] Transiently impaired endothelial function during thyroid hormone withdrawal in differentiated thyroid cancer patients
    Hou, Li-ying
    Li, Xiao
    Zhang, Guo-qiang
    Xi, Chuang
    Shen, Chen-tian
    Song, Hong-jun
    Bai, Wen-kun
    Qiu, Zhong-ling
    Luo, Quan-yong
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [38] High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal
    Bartenstein, Peter
    Caballero Calabuig, Elisa
    Maini, Carlo Ludovico
    Mazzarotto, Renzo
    Angustias Muros de Fuentes, M.
    Petrich, Thorsten
    Cravo Rodrigues, Fernando Jose
    Vallejo Casas, Juan Antonio
    Vianello, Federica
    Basso, Michela
    Gomez Balaguer, Marcelino
    Haug, Alexander
    Monari, Fabio
    Sanchez Vano, Raquel
    Sciuto, Rosa
    Magner, James
    [J]. THYROID, 2014, 24 (03) : 480 - 487
  • [39] Relationship between serum lipid profile and thyroid function after thyroid hormone withdrawal in patients with differentiated thyroid carcinoma
    杜娜
    [J]. China Medical Abstracts (Internal Medicine), 2016, 33 (02) : 19 - 20
  • [40] Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
    Wolfson, Robert M.
    Rachinsky, Irina
    Morrison, Deric
    Driedger, Al
    Spaic, Tamara
    van Uum, Stan H. M.
    [J]. JOURNAL OF ONCOLOGY, 2016, 2016